| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/13/2008 | WO2007120860A3 Nanoemulsion vaccines |
| 03/13/2008 | WO2007119108A3 Inositol derivatives and their uses in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, deposition, accumulation or persistence |
| 03/13/2008 | WO2007116428A3 Oral pharmaceutical composition containing cystine or cysteine with glutathione against oxidative stress resulting from haemodialysis |
| 03/13/2008 | WO2007113558A8 Quinazolinone derivatives having b-raf inhibitory activity |
| 03/13/2008 | WO2007113540A3 Regulating fat and carbohydrate oxidation in muscle tissue comprising controlling carnitine content in muscle |
| 03/13/2008 | WO2007112753A3 Pharmaceutical composition comprising anti-mirna antisense oligonucleotides |
| 03/13/2008 | WO2007109174A3 Compositions and methods for modulation of mcl-1 expression |
| 03/13/2008 | WO2007102149A3 Hydrazido derivatives of hyaluronic acid |
| 03/13/2008 | WO2007095603A3 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 03/13/2008 | WO2007095586A3 Neuronal pain pathway modulators |
| 03/13/2008 | WO2007092065A3 Compounds and compositions as lxr modulators |
| 03/13/2008 | WO2007085024A3 Dosage form and method for the delivery of drugs of abuse |
| 03/13/2008 | WO2007082914A3 Method of diagnosis and method of treatment |
| 03/13/2008 | WO2007082866A3 Use of chavicol for the treatment of superfinfected oily skin and scalp |
| 03/13/2008 | WO2007079391A3 Drug delivery system for bioadhesion to a vulvovaginal surface |
| 03/13/2008 | WO2007073505A3 Trpa1 inhibitors for treating pain |
| 03/13/2008 | WO2007053819A3 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods |
| 03/13/2008 | WO2007053574A3 Combinations comprising sorafenib and interferon for the treatment of cancer |
| 03/13/2008 | WO2007052167A3 Stable composition for a pharmaceutical formulation containing olanzapine |
| 03/13/2008 | WO2007048644A3 Prevention of retroviral infectivity through interference with ppt |
| 03/13/2008 | WO2007048628A3 Structures of active guide rna molecules and method of selection |
| 03/13/2008 | WO2007047998A3 Mutations and polymorphisms of hdac2 |
| 03/13/2008 | WO2007041053A3 Formulation comprising metformin and vildagli ptin |
| 03/13/2008 | WO2007010235A8 Ethanolamine salt of n- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-0xadiaz0le-2-yl] phenyl) pyridine-3- sulphonamide |
| 03/13/2008 | WO2006126747A3 Matrix metalloproteinase-9 inhibitor containing chlorogenic acid |
| 03/13/2008 | WO2006116353A8 N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions associated with oxidative stress |
| 03/13/2008 | WO2006106372A8 New crystalline atorvastatin hemicalcium salt polymorph form |
| 03/13/2008 | WO2006099385A8 Stabilized compositions of volatile alkylating agents and methods of using thereof |
| 03/13/2008 | WO2006078731A3 Amorphous and crystalline forms of dorzolamide hydrochloride and processes of making same |
| 03/13/2008 | WO2006042954A8 2-amido-4-phenylthiazole derivatives, the preparation and the therapeutic use thereof |
| 03/13/2008 | WO2001028491A3 Method and composition for the treatment of dermatologic diseases |
| 03/13/2008 | US20080064870 Pyrrolo[2,1-C][1,4]benzodiazepine hybrids and a process for the preparation thereof |
| 03/13/2008 | US20080064759 Process for preparing fenofibrate compositions |
| 03/13/2008 | US20080064758 Method of treatment or prophylaxis of depression |
| 03/13/2008 | US20080064757 Such as N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methyl-3-(naphthalen-1-ylsulfonyl)propanamide; acne, seborrhea, hirsutism, alopecia, hidradenitis suppurativa; prostate cancer |
| 03/13/2008 | US20080064755 Topical application of adapalene for the long-term treatment of acne vulgaris |
| 03/13/2008 | US20080064754 Amino ion releasing hydrogen bonded molecule |
| 03/13/2008 | US20080064753 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators |
| 03/13/2008 | US20080064752 Nonhygroscopic photosensitizing agents; sulphonate, hydrobromide, sulfate, nitrate and/or phosphate derivatives; diagnosing skin disorders |
| 03/13/2008 | US20080064751 Utilizing lipoxin analogs; polyisoprenyl phosphate signaling inhibition |
| 03/13/2008 | US20080064750 Shortenings and/or margarines with high diacylglycerol content; suppressing body absorption; low trans concentration; consistency, workability, mold releasability, melt behavior; heat resistance, shape retention, plasticity; texture, mouth feel |
| 03/13/2008 | US20080064749 Lipoxin Analogs as Novel Inhibitors of Angiogenesis |
| 03/13/2008 | US20080064748 Substituted enaminones, their derivatives and uses thereof |
| 03/13/2008 | US20080064747 Prevention of Neutrophil Recruitment |
| 03/13/2008 | US20080064746 Lipoxins and Aspirin-Triggered Lipoxins and Their Stable Analogs in the Treatment of Asthma and Inflammatory Airway Diseases |
| 03/13/2008 | US20080064745 Androgen Modulators |
| 03/13/2008 | US20080064744 Reduced gastrointestinal side effects of analgesic opioid therapy |
| 03/13/2008 | US20080064743 Dry powder compound formulations and uses thereof |
| 03/13/2008 | US20080064742 2,2-Difluoro-4-(4-hydroxy-phenyl)-6-methoxymethyl-1,2,3,3a,4,9b-hexahydro-cyclopenta[c]chromen-8-ol and formulations |
| 03/13/2008 | US20080064741 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/13/2008 | US20080064740 Novel Thiophene Derivatives |
| 03/13/2008 | US20080064739 Creatine pyroglutamic acid salts and methods for their production and use in individuals |
| 03/13/2008 | US20080064738 Neuroprotectants; preservation of cognitive activity in aging, neurodegenerative disease, reperfusion insult, ischemic brain infarction and cerebral ischemia; hydrosolubility, stability |
| 03/13/2008 | US20080064737 Neuroprotectants; preservation of cognitive activity in aging, neurodegenerative disease, reperfusion insult, ischemic brain infarction and cerebral ischemia; hydrosolubility, stability |
| 03/13/2008 | US20080064735 Method for controlling harmful organisms in crops of useful plants |
| 03/13/2008 | US20080064734 Mixture with other active materials; controlling glucose metabolism; diabetes |
| 03/13/2008 | US20080064733 MAGIs (membrane associated guanylate kinase proteins with inverse orientation); oncosuppressive (tumor suppressor) protein; (2-(1-Hydroxypentyl)-3-(2-phenylethyl)-6-methyl)indole-5-carboxylic acid |
| 03/13/2008 | US20080064731 Remedy for chronic disease |
| 03/13/2008 | US20080064729 Phenethylamide derivatives with kinase inhibitory activity |
| 03/13/2008 | US20080064728 Heterocyclic Compounds Useful as Dpp-Iv Inhibitors |
| 03/13/2008 | US20080064727 Crystalline forms of tiagabine hydrochloride |
| 03/13/2008 | US20080064726 Dipeptidyl peptidase-IV (DPP-IV) inhibitor; diabetes mellitus, insulin-resistant diseases, obesity, hypoglycemia ; 2-[4-({2-[(2S,4S)-2-cyano-4-fluoropyrrolidin-1-yl]-2-oxoethyl}amino)-4-methylpiperdin-1-yl]-2-oxoethyl acetate monofumarate |
| 03/13/2008 | US20080064725 Intrathecal administration of triptan compositions to treat non-migraine pain |
| 03/13/2008 | US20080064724 Composition Comprising Methylphenidate and Another Drug |
| 03/13/2008 | US20080064723 Anti-Hair Graying Agent |
| 03/13/2008 | US20080064722 Agent for promoting interferon-y production |
| 03/13/2008 | US20080064721 Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy |
| 03/13/2008 | US20080064720 Very Late Antigen-4 dependent inflammatory disease; asthma, allergic rhinitis, sinusitis, conjunctivitis, food allergy, inflammatory skin disorders, autoimmune disorders, or atherosclerosis, inflammatory skin disorder; methyl 3-[2-(2,6-dichlorophenyl)-6-quinolinyl]-2-hydroxy-2-propenoate |
| 03/13/2008 | US20080064719 Crf Receptor Antagonists And Methods Relating Thereto |
| 03/13/2008 | US20080064718 Inhibitors of protein tyrosine kinase activity |
| 03/13/2008 | US20080064717 Type 2 diabetes, obesity, elevated plasma triglycerides, metabolic syndrome, non-alcoholic steatohepatitis, and non-alcoholic fatty liver disease; N-(3-chlorophenyl)-N'-(4'-{(R)-hydroxy[(1R,2R)-2-(hydroxymethyl)cyclopentyl]methyl}-1,1'-biphenyl-4-yl)urea |
| 03/13/2008 | US20080064716 Biphenyl Integrin Antagonists |
| 03/13/2008 | US20080064715 I kappa B kinase inhibition; diabetes; (7-Chloro-1H-pyrrolo[2,3-c]pyridin-2-yl)methanol; N-Benzyl-7-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxamide |
| 03/13/2008 | US20080064714 Novel Pyrrolodihydroisoquinolines |
| 03/13/2008 | US20080064713 Dry Syrup Containing Loratadine |
| 03/13/2008 | US20080064712 17-allyl-4,5 alpha -epoxy-3-methoxy-14 beta -(3-phenylpropyloxy)morphinan-6-one with various substituents in Position 3 show higher analgesic activity than their 14-hydroxy analogues; opioid antagonists |
| 03/13/2008 | US20080064711 Composition for treating oral cavity and Mucousal infections |
| 03/13/2008 | US20080064710 Novel Hydantoin Derivatives for the Treatment of Obstructive Airway Diseases |
| 03/13/2008 | US20080064709 Methods and compositions for the treatment of vascular depression |
| 03/13/2008 | US20080064708 Substituted Pyrazinecarboxylic Acid Anilde Dervatives Or Salts Thereof, Intermediates Of The Same, Pesticides for Agricultural And Horticultural Use, and Usage Thereof |
| 03/13/2008 | US20080064707 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 03/13/2008 | US20080064706 Piperidine Derivatives as Histamine H3 Receptor Ligands |
| 03/13/2008 | US20080064705 Theophylline-based nitophenylpiperazine derivatives for enhancing aortic smooth muscle relaxation |
| 03/13/2008 | US20080064704 1,4-Diaryl-Dihydropyrimidin-2-Ones and Their Use as Human Neutrophil Elastase Inhibitors |
| 03/13/2008 | US20080064703 Fused bicycloheterocycle substituted quinuclidine derivatives |
| 03/13/2008 | US20080064702 Use of folates for the prevention and treatment of vascular diseases |
| 03/13/2008 | US20080064701 Controlling blood glucose levels in type 2 diabetic patients with dipeptidyl peptidase-4 proteolytic activity inhibitor and biguanide slow release medicant |
| 03/13/2008 | US20080064700 Aryl triazines as LPAAT-beta inhibitors and uses thereof |
| 03/13/2008 | US20080064699 Novel compounds as cannabinoid receptor ligands and uses thereof |
| 03/13/2008 | US20080064697 Antidiabetic agents; somatostatin receptor subtype 5 modulators; noninsulin dependent diabetes mellitus; side effect reduction; synthesis |
| 03/13/2008 | US20080064696 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 03/13/2008 | US20080064695 Neuronal nicotinic acetylcholine receptor modulators; such as ethyl 1-[4-(aminosulfonyl)phenyl]-5-(4-bromophenyl)-2-methyl-1H-pyrrole-3-carboxylate |
| 03/13/2008 | US20080064694 Multi-Phase Release Methscopolamine Compositions |
| 03/13/2008 | US20080064693 N-2 Adamantanyl-2-Phenoxy-Acetamide Derivatives as 11-Beta Hydroxysteroid Dehydrogenase Inhibitors |
| 03/13/2008 | US20080064691 Heterocyclic Amide Derivatives Which Possess Glycogen Phosphorylase Inhibitory Activity |
| 03/13/2008 | US20080064690 Neuropathic or inflammatory pain relief; inhibiting ion flux through channel including PN3 subunit; potency |
| 03/13/2008 | US20080064689 Containing substituted oxazolidinone and isoxazoline rings; effective against antibiotic resistance strains; gram positive and Gram negative pathogens |
| 03/13/2008 | US20080064688 Anti-inflammatory medicaments |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/13/2008 | US20080064686 Programmed cell death, autoimmunity, inflammation, hyperproliferation; easy formulation, shelf life |